Safety and immunogenicity of one or two doses of the rVSVΔG-ZEBOV-GP Ebola virus vaccine in adults and adolescents living with HIV: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial [0.03%]
一种或两种剂量的rVSVΔG-ZEBOV-GP埃博拉疫苗在成年和青少年HIV感染者中的安全性及免疫原性：一项多中心、双盲、随机、安慰剂对照二期临床试验
Cécile Tremblay,Innocent Valea,Birahim Pierre Ndiaye et al.
Cécile Tremblay et al.
Background: A single dose of the replication-competent rVSVΔG-ZEBOV-GP vaccine is recommended by the WHO Strategic Advisory Group of Experts on Immunization during Ebola virus disease outbreaks. We aimed to assess the im...
Highlights of AIDS 2026 [0.03%]
艾滋病2026大会亮点
Adrian Gonzalez Lopez
Adrian Gonzalez Lopez
Evolving understanding of Kaposi sarcoma and associated diseases in the ART era [0.03%]
抗艾滋病病毒治疗时代Kaposi肉瘤及相关疾病的诊治进展
Nazzarena Labo,Elena M Cornejo Castro,Vickie A Marshall et al.
Nazzarena Labo et al.
Kaposi sarcoma (KS)-associated herpesvirus (KSHV), otherwise known as HHV-8, causes KS and several lymphoproliferative disorders including KSHV-associated multicentric Castleman disease, KSHV-associated inflammatory cytokine syndrome, prima...
Roger Pebody
Roger Pebody
Interventions to improve viral suppression and adherence to antiretroviral therapy among people living with HIV: a systematic review and network meta-analysis [0.03%]
改善HIV感染者病毒抑制和抗逆转录病毒治疗依从性的干预措施：系统评价和网络meta分析
Steve Kanters,David S Lawrence,Vanessa S McLennan et al.
Steve Kanters et al.
Background: In 2025, 78% of people living with HIV worldwide were on antiretroviral therapy 95% of people on treatment were virally suppressed. Suboptimal adherence, defined as not taking interventions as prescribed, thre...
Does U=U apply during breastfeeding? An urgent research priority [0.03%]
关于纯母乳喂养的“治疗即预防”策略：亟待解决的一项研究课题
Dvora Joseph Davey,Shahin Lockman,Roger Shapiro et al.
Dvora Joseph Davey et al.
Whether undetectable equals untransmittable (U=U) applies during breastfeeding remains one of the most consequential unanswered questions in HIV prevention. Although sustained viral suppression eliminates sexual HIV transmission, evidence i...
Durability of HIV viral suppression in South Africa: a national cohort study [0.03%]
南非艾滋病病毒抑制的持久性：一项全国队列研究
Evelyn Lauren,Jacob Bor,Trevor Graham Bell et al.
Evelyn Lauren et al.
Background: People with an HIV viral load less than 200 copies per mL cannot transmit HIV sexually, but viral rebound can lead to transmission risk. We aimed to quantify 12-month durability of viral suppression in South A...
Observational Study
The lancet. HIV. 2026 Aug;13(8):e548-e556. DOI:10.1016/S2352-3018(26)00079-2 2026
Nigel Garrett,Jienchi Dorward
Nigel Garrett
The Lancet Hiv
The Lancet Hiv